Cook, Colton, Gunther, Peoples-Stokes, Cahill, Englebright, Miller
MLTSPNSR
Brennan, Farrell, Gottfried, Lupardo, Rivera
Amd SS3216, 3221 & 4303, Ins L
Requires that insurance companies provide coverage for surveillance tests for ovarian cancer of insured individuals who are deemed to be at risk for ovarian cancer.
STATE OF NEW YORK
________________________________________________________________________
8560
2015-2016 Regular Sessions
IN ASSEMBLY
October 30, 2015
___________
Introduced by M. of A. ORTIZ, COOK, COLTON, CLARK, GUNTHER,
PEOPLES-STOKES, CAHILL, ENGLEBRIGHT, MILLER -- Multi-Sponsored by --
M. of A. BRENNAN, FARRELL, GOTTFRIED, LUPARDO, RIVERA -- read once and
referred to the Committee on Insurance
AN ACT to amend the insurance law, in relation to providing coverage for
surveillance tests for ovarian cancer
The People of the State of New York, represented in Senate and Assem-bly, do enact as follows:
1 Section 1. Subsection (i) of section 3216 of the insurance law is
2 amended by adding a new paragraph 32 to read as follows:
3 (32) Every policy that provides medical, major-medical or similar
4 comprehensive-type coverage shall provide coverage for surveillance
5 tests for ovarian cancer for an insured who is at risk for ovarian
6 cancer. (A) For purposes of this subsection, an insured is deemed to be
7 at risk if:
8 (i) she has a family history of:
9 1. one or more first-degree relative with ovarian cancer;
10 2. three or more female relatives with breast cancer; or
11 3. nonpolyposis colorectal cancer; or
12 (ii) she tests positive for BRCA1 or BRCA2 mutations.
13 (B) For purposes of this subsection, surveillance tests for ovarian
14 cancer shall mean annual screening for ovarian cancer using:
15 (i) CA-125 serum tumor marker testing;
16 (ii) transvaginal ultrasound; and
17 (iii) pelvic examination.
18 § 2. Subsection (k) of section 3221 of the insurance law is amended by
19 adding a new paragraph 20 to read as follows:
20 (20) Every group or blanket policy delivered or issued for delivery in
21 this state which provides hospital, surgical or medical coverage shall
22 include coverage for surveillance tests for ovarian cancer for an
EXPLANATION--Matter in italics (underscored) is new; matter in brackets
[] is old law to be omitted.
LBD04600-02-5
A. 8560 2
1 insured who is at risk for ovarian cancer. (A) For purposes of this
2 subsection, an insured is deemed to be at risk if:
3 (i) she has a family history of:
4 1. one or more first-degree relative with ovarian cancer;
5 2. three or more female relatives with breast cancer; or
6 3. nonpolyposis colorectal cancer; or
7 (ii) she tests positive for BRCA1 or BRCA2 mutations.
8 (B) For purposes of this subsection, surveillance tests for ovarian
9 cancer shall mean annual screening for ovarian cancer using:
10 (i) CA-125 serum tumor marker testing;
11 (ii) transvaginal ultrasound; and
12 (iii) pelvic examination.
13 § 3. Section 4303 of the insurance law is amended by adding a new
14 subsection (pp) to read as follows:
15 (pp) A health service corporation or medical expense indemnity corpo-
16 ration which provides medical, major-medical or similar comprehensive-
17 type coverage must provide coverage for surveillance tests for ovarian
18 cancer for an insured who is at risk for ovarian cancer. (1) For
19 purposes of this subsection, an insured is deemed to be at risk if:
20 (A) she has a family history of:
21 (i) one or more first-degree relative with ovarian cancer;
22 (ii) three or more female relatives with breast cancer; or
23 (iii) nonpolyposis colorectal cancer; or
24 (B) she tests positive for BRCA1 or BRCA2 mutations.
25 (2) For purposes of this subsection, surveillance tests for ovarian
26 cancer shall mean annual screening for ovarian cancer using:
27 (A) CA-125 serum tumor marker testing;
28 (B) transvaginal ultrasound; and
29 (C) pelvic examination.
30 § 4. This act shall take effect immediately and shall apply to any
31 policy issued, renewed, or modified after such effective date.
